The chairman of the U.S. Senate Judiciary Committee last month urged federal antitrust officials to conduct a “careful analysis” of the merger between Dow and DuPont.
Advertisement
Ed Breen, DuPont’s chief executive, said the company expects the deal to close later the year.
DuPont and Dow have offered concessions in a bid to allay EU antitrust concerns about their proposed $130 billion merger, according to a filing on the European Commission’s website. The new separate companies, each to be publicly traded, would focus on agriculture, material sciences and specialty products in nutrition and electronics. “We’re pretty far down the road on who those candidates will be”, he said.
The U.S. Department of Justice is also examining the deal.
Upon the merger’s completion, which Mr. Breen said he anticipates sometime in November, DowDuPont will likely face continued challenges across its major business lines. But the company on Tuesday provided a fresh reminder of what it is capable on its own, reporting results that topped expectations. DuPont in January had estimated a 30-cent hit.
The Wilmington-based chemical company reported more than $1 billion in profits in the second quarter, up from $994 million during the second quarter of 2015.
DuPont’s sales in the quarter edged down 0.8% to $7.06 billion. Full-year operating earnings excluding restructuring costs and other items will be $3.15 to $3.20 a share, DuPont said in a statement Tuesday.
Advertisement
-Joshua Jamerson contributed to this article.
